نتایج جستجو برای: lymphocytic leukemia

تعداد نتایج: 291188  

Journal: :Haematologica 2013
Robin Foà Ilaria Del Giudice Anna Guarini Davide Rossi Gianluca Gaidano

Genetics and molecular genetics have contributed to clarify the biological bases of the clinical heterogeneity of chronic lymphocytic leukemia. In recent years, our knowledge of the molecular genetics of chronic lymphocytic leukemia has significantly broadened, offering potential new clinical implications. Mutations of TP53 and ATM add prognostic information independently of fluorescence in sit...

Journal: :Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2015
M Špaček

Chronic lymphocytic leukemia is one of the most common lymphoid malignancies and is characterized by a highly heterogeneous clinical course. Combined regimens, such as fludarabine, cyclophosphamide, and rituximab have led to improvements in survival in younger patients with chronic lymphocytic leukemia and have become the standard of care in fit patients. However, the majority of chronic lympho...

Journal: :Haematologica 2013
Laia Rosich Ifigènia Saborit-Villarroya Mónica López-Guerra Sílvia Xargay-Torrent Arnau Montraveta Marta Aymerich Neus Villamor Elias Campo Patricia Pérez-Galán Gaël Roué Dolors Colomer

Phosphatidylinositol-3-kinase pathway is constitutively activated in chronic lymphocytic leukemia mainly due to microenvironment signals, including stromal cell interaction and CXCR4 and B-cell receptor activation. Because of the importance of phosphatidylinositol-3-kinase signaling in chronic lymphocytic leukemia, we investigated the activity of the NVP-BKM120, an orally available pan class I ...

Journal: :Blood 1973
E Hinkes B F Crandall F Weber C G Craddock

characterized by a specific chromosomal marker (the Philadelphia chromosome, Ph’), a significant percentage of all morphologic types of leukemia, except possibly chronic lymphocytic leukemia, will demonstrate aneuploidy. This report describes the occurrence of acute lymphocytic leukemia (ALL) in a young man with a balanced C-G translocation, t(Cp; Gp+), a rare chromosomal abnormality not previo...

2016
Luciana de Sales Caldato Juliana de Sousa Britto Ligia Niero-Melo Hélio Amante Miot

Bullous leukemia cutis is an uncommon clinical manifestation of cutaneous infiltration by leukemic cells, from B-cell chronic lymphocytic leukemia. We present the case of a 67-year-old, female, chronic lymphocytic leukemia patient. She was taking chlorambucil and developed facial edema with erythema and warmth, misjudged as facial cellulitis. Two days later, she developed bullous lesions in the...

2014
Katarina Holanda Antonio Roberto Lucena-Araujo Adônis Quintas Taciana Mendonça Aleide Lima Luydson Richardson Vasconcelos Patrícia Moura Maria Cavalcanti Cíntia Machado Aderson Silva Araújo Marcos Andre Bezerra

BACKGROUND Infectious complications represent the main cause of morbidity and mortality in chronic lymphocytic leukemia. It has been reported that polymorphisms of the mannosebinding lectin 2 (MBL2) genes are correlated with MBL protein serum levels and, consequently, are associated with the development of infectious diseases. OBJECTIVE The purpose of this study was to investigate the possibl...

Journal: :Haematologica 2013
Jennifer R Brown Bradley Messmer Lillian Werner Matthew S Davids Evgeny Mikler Jeffrey G Supko David C Fisher Ann S LaCasce Philippe Armand Eric Jacobsen Virginia Dalton Bethany Tesar Stacey M Fernandes Sean McDonough Jerome Ritz Laura Rassenti Thomas J Kipps Donna Neuberg Arnold S Freedman

This study assessed the safety and preliminary efficacy of escalated dose subcutaneous alemtuzumab in combination with rituximab in chronic lymphocytic leukemia. Twenty-eight patients with relapsed refractory chronic lymphocytic leukemia were treated on four dosing cohorts of weekly rituximab at 375 mg/m(2) and alemtuzumab doses that started at 30 mg three times per week and escalated to weekly...

2017
Mika Shapiro Yair Herishanu Ben-Zion Katz Nili Dezorella Clare Sun Sigi Kay Aaron Polliack Irit Avivi Adrian Wiestner Chava Perry

A novel therapeutic approach in cancer, attempting to stimulate host anti-tumor immunity, involves blocking of immune checkpoints. Lymphocyte activation gene 3 (LAG3) is an immune checkpoint receptor expressed on activated/exhausted T cells. When engaged by the major histocompatibility complex (MHC) class II molecules, LAG3 negatively regulates T-cell function, thereby contributing to tumor esc...

2010
Elaine Lin Adrienne Boire Vagish Hemmige Aliya N Husain Matthew Sorrentino Sandeep Nathan Shahab A Akhter Jerome Dickstein Stephen L Archer

INTRODUCTION Chronic lymphocytic leukemia is an indolent disease that often presents with complaints of lymphadenopathy or is detected as an incidental laboratory finding. It is rarely considered in the differential diagnosis of patients presenting with tamponade or a large, bloody pericardial effusion. In patients without known cancer, a large, bloody pericardial effusion raises the possibilit...

2017
Antonella Zagaria Luisa Anelli Nicoletta Coccaro Giuseppina Tota Claudia Brunetti Angela Minervini Paola Casieri Luciana Impera Crescenzio Francesco Minervini Annamaria Giordano Paola Orsini Cosimo Cumbo Giorgina Specchia Francesco Albano

NR: Not reported, FCR: fludarabine, cyclophosphamide, rituximab; MUD AHSCT: matched unrelated donor allogeneic hematopoietic stem cell transplantation, CR: complete remission, CLL: chronic lymphocytic leukemia, SM: systemic mastocytosis. Systemic Mastocytosis with Associated Chronic Lymphocytic Leukemia: A Matter of Diseases or Prognostic Factors? Kronik Lenfositik Lösemi ile Birlikte Seyreden ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید